TCRX

TSCAN THERAPEUTICS INC

TCRX·89854M101·US·Common Stock·Healthcare - Biotechnology-13D/G

TCRX (TSCAN THERAPEUTICS INC) is held by 38 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($2.7M), VANGUARD CAPITAL MANAGEMENT LLC ($2.1M), TWO SIGMA INVESTMENTS, LP ($1.9M). Net institutional sentiment: Mixed.

38
Holders
(1 Elite)
$16.1M
Total Value
57% (35)
Consensus
20 buying - 15 selling
13F: Insider & Congress: Updated regularly
TCRX

Smart Money Verdict

View all
Loading verdict
Held by 38 funds
1 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Dec 23, 2025 · Activists Aug 14, 2026 · Congress none

ActivistBLBVF PARTNERS L P/IL10.0%Aug 14, 2026
ActivistLYLynx1 Capital Management LP13.1%Aug 14, 2026
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
2.8M$2.7M0.0%-86.84%
0
Increased
2.2M(+0.2%)$2.1M0.0%-24.52%
18
Increased
1.9M(+61.3%)$1.9M0.0%-29.19%
37
Decreased
1.3M(-2.8%)$1.3M0.0%-39.85%
0
Decreased
1.2M(-20.3%)$1.1M0.0%-31.03%
0
Increased
1M(+29.9%)$1M0.0%-23.67%
32
Increased
1M(+216.9%)$989,0260.0%-30.32%
40
Decreased
994,654(-46.0%)$974,8600.0%-74.09%
0
Increased
687,364(+189.6%)$673,6160.0%-23.39%
40
Decreased
584,811(-5.2%)$573,4010.0%-82.43%
0
Increased
548,402(+71.6%)$537,4890.0%-22.96%
36
Increased
363,954(+19.0%)$356,6750.0%-23.93%
28
Increased
241,493(+67.2%)$236,6870.0%-26.40%
23
Unchanged
207,313$203,1870.0%-85.66%
0
Increased
197,891(+14.0%)$193,9520.0%-72.70%
18
Increased
149,467(+146.2%)$146,4930.0%-24.04%
36
Unchanged
143,051$140,2040.0%-85.79%
0
Increased
138,778(+42.4%)$136,0160.0%-77.38%
20
Unchanged
91,463$89,6430.0%-49.85%
0
Increased
70,514(+89.2%)$69,1110.0%-48.76%
23

Showing 1-20 of 44

1 / 3
TCRXTCRXTSCAN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used